{"id":"antimony","rwe":[],"_fda":{"id":"2cc87194-4ca1-f4af-e063-6294a90a596b","set_id":"0991be25-8930-3c09-e063-6294a90ac5e2","openfda":{"unii":["F79059A38U"],"route":["ORAL"],"spl_id":["2cc87194-4ca1-f4af-e063-6294a90a596b"],"brand_name":["Antimonium Crudum Kit Refill"],"spl_set_id":["0991be25-8930-3c09-e063-6294a90ac5e2"],"package_ndc":["71919-812-01"],"product_ndc":["71919-812"],"generic_name":["ANTIMONY TRISULFIDE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["ANTIMONY TRISULFIDE"],"manufacturer_name":["Washington Homeopathic Products"],"is_original_packager":[true]},"purpose":["USES To relieve the symptoms of warts."],"version":"4","warnings":["STOP USE AND ASK DOCTOR If symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner."],"effective_time":"20250128","active_ingredient":["ACTIVE INGREDIENTS ANTIMONIUM CRUDUM 30C"],"inactive_ingredient":["INACTIVE INGREDIENTS Sucrose/Lactose"],"indications_and_usage":["INDICATIONS Indications: ANTIMONIUM CRUDUM Warts"],"dosage_and_administration":["DIRECTIONS Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides."],"spl_product_data_elements":["Antimonium Crudum Kit Refill ANTIMONY TRISULFIDE SUCROSE LACTOSE ANTIMONY TRISULFIDE ANTIMONY CATION (3+) white"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN Keep this and all medicines out of reach of children."],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL Ant cru kit refill 200c"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"Warts","category":"indication"},{"label":"Washington Homeopathic Products","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"54 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"49 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"49 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"40 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"39 reports"},{"date":"","signal":"ARTHRALGIA","source":"FDA FAERS","actionTaken":"34 reports"},{"date":"","signal":"PNEUMONIA","source":"FDA FAERS","actionTaken":"34 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"33 reports"},{"date":"","signal":"FALL","source":"FDA FAERS","actionTaken":"33 reports"},{"date":"","signal":"ASTHENIA","source":"FDA FAERS","actionTaken":"30 reports"}]},"trials":[],"aliases":[],"company":"Washington Homeopathic Products","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ANTIMONY","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:12.020488+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:19.312160+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ANTIMONY","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:20.517867+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:09.777510+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:18:09.777566+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:18:22.049524+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297652/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:20.989148+00:00"}},"allNames":"antimonium crudum kit refill","offLabel":[],"synonyms":["Antimonium Crudum Kit Refill","ANTIMONY TRISULFIDE"],"timeline":[],"approvals":[],"brandName":"Antimonium Crudum Kit Refill","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"As a small molecule, Antimonium Crudum Kit Refill is likely to interact with various biological targets, including enzymes, receptors, and other molecules involved in the immune response and skin regeneration. Further research is needed to identify the specific molecular mechanisms underlying its effects on warts and to fully understand its pharmacokinetic and pharmacodynamic properties."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"ANTIMONY\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=antimony","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=antimony","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:38:25.642909","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:23.759758+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"antimony","indications":{"approved":[{"name":"Warts","source":"OpenFDA Label","regulator":"FDA","eligibility":"No specific eligibility criteria mentioned"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07197944","phase":"PHASE3","title":"Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS","status":"RECRUITING","sponsor":"Zealand Pharma","startDate":"2026-02-11","conditions":["Short Bowel Syndrome"],"enrollment":90,"completionDate":"2032-02-28"},{"nctId":"NCT07496944","phase":"NA","title":"Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue","status":"COMPLETED","sponsor":"Beijing Sport University","startDate":"2026-01-20","conditions":["Athletic Performance"],"enrollment":40,"completionDate":"2026-03-22"},{"nctId":"NCT07319832","phase":"","title":"A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-03-05","conditions":["Short Bowel Syndrome (SBS)"],"enrollment":12,"completionDate":"2027-09-30"},{"nctId":"NCT07463040","phase":"PHASE3","title":"Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)","status":"NOT_YET_RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2027-01-01","conditions":["Cutaneous Leihmaniasis"],"enrollment":900,"completionDate":"2029-08-31"},{"nctId":"NCT06771505","phase":"","title":"SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-01-15","conditions":["Short Bowel Syndrome"],"enrollment":100,"completionDate":"2027-01-01"},{"nctId":"NCT06326645","phase":"EARLY_PHASE1","title":"Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome","status":"RECRUITING","sponsor":"Lindsey Russell, MD","startDate":"2025-03-03","conditions":["Short Bowel Syndrome"],"enrollment":6,"completionDate":"2026-02-01"},{"nctId":"NCT04881825","phase":"PHASE3","title":"Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zealand Pharma","startDate":"2021-06-16","conditions":["Short Bowel Syndrome"],"enrollment":129,"completionDate":"2026-04"},{"nctId":"NCT07228403","phase":"PHASE3","title":"Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Zealand Pharma","startDate":"2025-12-11","conditions":["Short Bowel Syndrome (SBS)"],"enrollment":35,"completionDate":"2028-12-31"},{"nctId":"NCT06097156","phase":"","title":"Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications","status":"RECRUITING","sponsor":"Tethis S.p.A.","startDate":"2023-11-06","conditions":["Healthy Participants","Breast Cancer"],"enrollment":45,"completionDate":"2026-12"},{"nctId":"NCT03905707","phase":"PHASE3","title":"Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zealand Pharma","startDate":"2019-05-07","conditions":["Short Bowel Syndrome"],"enrollment":145,"completionDate":"2026-04"},{"nctId":"NCT06233578","phase":"NA","title":"ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2024-01-10","conditions":["Radiation Exposure"],"enrollment":1000,"completionDate":"2024-12-31"},{"nctId":"NCT07297238","phase":"NA","title":"Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.","status":"NOT_YET_RECRUITING","sponsor":"Jinling Hospital, China","startDate":"2026-01-01","conditions":["Short Bowel Syndrome (SBS)","Intestinal Failure"],"enrollment":20,"completionDate":"2026-03-31"},{"nctId":"NCT05957978","phase":"PHASE2","title":"LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2024-03-29","conditions":["Primary Visceral Leishmaniasis"],"enrollment":52,"completionDate":"2025-11-13"},{"nctId":"NCT04775706","phase":"PHASE2","title":"Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects","status":"RECRUITING","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2022-03-03","conditions":["Short Bowel Syndrome"],"enrollment":18,"completionDate":"2028-05"},{"nctId":"NCT07252024","phase":"NA","title":"Nurse-Led BIS-Guided Sedation Protocol in Pediatric Intensive Care","status":"COMPLETED","sponsor":"Dr. Behcet Uz Children's Hospital","startDate":"2024-06-01","conditions":["Nurse's Role","Bispectral Index","Pediatric Sedation"],"enrollment":88,"completionDate":"2025-08-01"},{"nctId":"NCT06240065","phase":"NA","title":"Successful Fiber Food Introduction in Short Bowel Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-04-19","conditions":["Short Gut Syndrome"],"enrollment":60,"completionDate":"2028-04"},{"nctId":"NCT07235670","phase":"NA","title":"Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2021-06-01","conditions":["Short Bowel Syndrome","Intestinal Resection"],"enrollment":39,"completionDate":"2022-06-16"},{"nctId":"NCT01990040","phase":"","title":"Registry for Participants With Short Bowel Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shire","startDate":"2014-06-23","conditions":["Short Bowel Syndrome"],"enrollment":1806,"completionDate":"2032-06-30"},{"nctId":"NCT06798402","phase":"PHASE2","title":"Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate","status":"RECRUITING","sponsor":"Al-Mustafa University College","startDate":"2025-02-07","conditions":["Cutaneous Leishmaniasis"],"enrollment":80,"completionDate":"2025-11-01"},{"nctId":"NCT07186608","phase":"NA","title":"Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation.","status":"COMPLETED","sponsor":"Jinling Hospital, China","startDate":"2025-02-05","conditions":["Short Bowel Syndrome"],"enrollment":10,"completionDate":"2025-08-15"},{"nctId":"NCT05967871","phase":"PHASE1","title":"Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth","status":"RECRUITING","sponsor":"McMaster Children's Hospital","startDate":"2024-03-11","conditions":["Small Intestinal Bacterial Overgrowth"],"enrollment":20,"completionDate":"2026-12-31"},{"nctId":"NCT05432648","phase":"NA","title":"Fiber Food Introduction in Pediatric Short Bowel Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2022-05-08","conditions":["Short Gut Syndrome"],"enrollment":60,"completionDate":"2026-05"},{"nctId":"NCT04342715","phase":"","title":"A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of York","startDate":"2022-05-22","conditions":["Visceral Leishmaniasis"],"enrollment":216,"completionDate":"2026-03-31"},{"nctId":"NCT03690206","phase":"PHASE3","title":"Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)","status":"COMPLETED","sponsor":"Zealand Pharma","startDate":"2018-10-04","conditions":["Short Bowel Syndrome"],"enrollment":106,"completionDate":"2022-07-26"},{"nctId":"NCT05018286","phase":"PHASE3","title":"Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.","status":"ACTIVE_NOT_RECRUITING","sponsor":"VectivBio AG","startDate":"2021-07-13","conditions":["Short Bowel Syndrome"],"enrollment":158,"completionDate":"2027-10-30"},{"nctId":"NCT07037914","phase":"NA","title":"The Impact of the Nurse-Led \"My Baby is Safe\" Educational Program","status":"NOT_YET_RECRUITING","sponsor":"Amasya University","startDate":"2025-07","conditions":["Sudden Infant Death Syndrome","Shaken Baby Syndrome"],"enrollment":50,"completionDate":"2026-08"},{"nctId":"NCT04964986","phase":"PHASE2","title":"Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)","status":"COMPLETED","sponsor":"VectivBio AG","startDate":"2021-06-14","conditions":["Short Bowel Syndrome"],"enrollment":10,"completionDate":"2023-06-06"},{"nctId":"NCT06904872","phase":"PHASE2","title":"Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)","status":"RECRUITING","sponsor":"Napo Therapeutics, S.p.A.","startDate":"2025-05-29","conditions":["Short Bowel Syndrome","Malabsorption Syndromes","Short Gut Syndrome","Post-Op Complication","Functional Gastrointestinal Disorders"],"enrollment":18,"completionDate":"2026-02"},{"nctId":"NCT05371028","phase":"","title":"A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada","status":"COMPLETED","sponsor":"Takeda","startDate":"2023-09-23","conditions":["Short Bowel Syndrome (SBS)"],"enrollment":52,"completionDate":"2025-02-19"},{"nctId":"NCT02954458","phase":"PHASE3","title":"Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)","status":"COMPLETED","sponsor":"Shire","startDate":"2017-01-09","conditions":["Short Bowel Syndrome"],"enrollment":61,"completionDate":"2020-11-05"},{"nctId":"NCT06777251","phase":"NA","title":"Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-02-29","conditions":["Intestinal Failure","Inflammatory Bowel Diseases","Crohn Disease"],"enrollment":254,"completionDate":"2025-05-18"},{"nctId":"NCT05111405","phase":"NA","title":"Study Comparing SBS and LRTI for Treatment of CMC Arthritis","status":"RECRUITING","sponsor":"Fraser Orthopaedic Research Society","startDate":"2022-06-20","conditions":["Arthritis"],"enrollment":138,"completionDate":"2026-05"},{"nctId":"NCT04627025","phase":"PHASE3","title":"Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF","status":"COMPLETED","sponsor":"VectivBio AG","startDate":"2021-01-26","conditions":["Short Bowel Syndrome"],"enrollment":164,"completionDate":"2024-02-22"},{"nctId":"NCT04991311","phase":"PHASE3","title":"The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome","status":"COMPLETED","sponsor":"Zealand Pharma","startDate":"2021-08-10","conditions":["Short Bowel Syndrome"],"enrollment":12,"completionDate":"2023-09-05"},{"nctId":"NCT05441345","phase":"","title":"Sarcopenia and Short Bowel Syndrome","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-08-18","conditions":["Short Bowel Syndrome"],"enrollment":110,"completionDate":"2024-07-16"},{"nctId":"NCT03408132","phase":"PHASE1,PHASE2","title":"Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency","status":"COMPLETED","sponsor":"GlyPharma Therapeutics","startDate":"2018-05-02","conditions":["SBS - Short Bowel Syndrome"],"enrollment":8,"completionDate":"2019-10-28"},{"nctId":"NCT06427642","phase":"NA","title":"Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases","status":"RECRUITING","sponsor":"Shandong Qilu Stem Cells Engineering Co., Ltd.","startDate":"2022-04-01","conditions":["Hypoxic-Ischemic Encephalopathy","Bronchopulmonary Dysplasia","Short Bowel Syndrome"],"enrollment":120,"completionDate":"2025-04-30"},{"nctId":"NCT05706012","phase":"","title":"Antithrombotic Management of Acute Mesenteric Ischaemia","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2023-06-30","conditions":["Acute Mesenteric Ischemia","Short Bowel Syndrome"],"enrollment":51,"completionDate":"2024-02-29"},{"nctId":"NCT05788250","phase":"NA","title":"RC Repair Versus Subacromial Balloon Spacer in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Panam Clinic","startDate":"2024-08","conditions":["Rotator Cuff Tears"],"enrollment":32,"completionDate":"2027-10"},{"nctId":"NCT05922189","phase":"NA","title":"The Effect of the SBS Decompression Technique on Gastrointestinal Symptoms During the Menstrual Cycle","status":"NOT_YET_RECRUITING","sponsor":"Escola Superior de Tecnologia da Saúde do Porto","startDate":"2024-09-01","conditions":["Healthy"],"enrollment":60,"completionDate":"2024-12-31"},{"nctId":"NCT06334978","phase":"NA","title":"The Effectiveness of Osteopathic Treatment in Cervical Whiplash.","status":"COMPLETED","sponsor":"Hospital San Juan de Dios del Aljarafe de Sevilla","startDate":"2021-01-13","conditions":["Whiplash Injury of Cervical Spine","Osteopathia","Quality of Life","Chronic Pain Syndrome"],"enrollment":52,"completionDate":"2022-08-10"},{"nctId":"NCT04699383","phase":"","title":"Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2021-02-15","conditions":["Cutaneous Leishmaniasis"],"enrollment":105,"completionDate":"2022-12-15"},{"nctId":"NCT04799236","phase":"PHASE3","title":"Treatment of Mucosal Bolivian Leishmaniasis","status":"RECRUITING","sponsor":"Fundacion Nacional de Dermatologia","startDate":"2021-04-01","conditions":["Mucosal Leishmaniasis"],"enrollment":120,"completionDate":"2024-11-30"},{"nctId":"NCT03129646","phase":"PHASE3","title":"Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2018-01-24","conditions":["Visceral Leishmaniasis"],"enrollment":439,"completionDate":"2020-12-11"},{"nctId":"NCT06045039","phase":"","title":"Clinical Efficacy of Stent-balloon-stent (SBS) Technique in the Treatment of Coronary Bifurcation Lesions","status":"UNKNOWN","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2023-01-01","conditions":["Coronary Disease","Heart Diseases","Cardiovascular Diseases","Vascular Diseases","Myocardial Ischemia"],"enrollment":200,"completionDate":"2024-12-31"},{"nctId":"NCT06237530","phase":"PHASE1,PHASE2","title":"Interoception and Body Scan","status":"COMPLETED","sponsor":"University of Valencia","startDate":"2023-07-26","conditions":["Healthy"],"enrollment":48,"completionDate":"2023-08-21"},{"nctId":"NCT00508963","phase":"","title":"Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis","status":"NO_LONGER_AVAILABLE","sponsor":"University of California, San Francisco","startDate":"","conditions":["Leishmaniasis, Cutaneous","Leishmaniasis, Mucocutaneous"],"enrollment":0,"completionDate":""},{"nctId":"NCT05168020","phase":"NA","title":"Evaluation of a Self-Monitoring Intervention to Reduce Safety Behavior in Social Anxiety","status":"COMPLETED","sponsor":"Florida State University","startDate":"2021-09-28","conditions":["Social Anxiety"],"enrollment":154,"completionDate":"2022-11-24"},{"nctId":"NCT04832087","phase":"","title":"Pediatric Teduglutide Registry","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2021-05-18","conditions":["Short Bowel Syndrome"],"enrollment":142,"completionDate":"2023-08-31"},{"nctId":"NCT06110871","phase":"NA","title":"\"The Effect of Inhaler Lavender, Focus and Music on Women's Pain, Anxiety, in Intrauterine Device Application\"","status":"UNKNOWN","sponsor":"Turkish Ministry of Health, Kahramanmaras Provincial Health Directorate","startDate":"2023-10-19","conditions":["Visual Analog Pain Scale"],"enrollment":240,"completionDate":"2023-12-30"},{"nctId":"NCT05544877","phase":"NA","title":"An Energetic View on Creativity, Psychopathology and Intelligence: The Brain2Business Study","status":"COMPLETED","sponsor":"Psychiatrische Dienste Thurgau","startDate":"2022-07-19","conditions":["General Psychopathology","Fatigue","Depressive Disorder, Major"],"enrollment":200,"completionDate":"2023-10-04"},{"nctId":"NCT06102668","phase":"","title":"Survival and PN Dependence in SBS Patients","status":"COMPLETED","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2012-01-01","conditions":["Short Bowel Syndrome"],"enrollment":173,"completionDate":"2019-01-01"},{"nctId":"NCT00742157","phase":"PHASE4","title":"Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2003-09-01","conditions":["Short Bowel Syndrome"],"enrollment":5,"completionDate":"2008-10-20"},{"nctId":"NCT04883606","phase":"","title":"A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome","status":"COMPLETED","sponsor":"Takeda","startDate":"2022-01-26","conditions":["Short Bowel Syndrome"],"enrollment":65,"completionDate":"2023-07-24"},{"nctId":"NCT06000514","phase":"PHASE1,PHASE2","title":"Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.","status":"COMPLETED","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2019-01-17","conditions":["Cutaneous Leishmaniasis, American"],"enrollment":20,"completionDate":"2022-07-07"},{"nctId":"NCT05742529","phase":"NA","title":"Cosmotic Outcome of Distal Penile Hypospidias Repair Using Stitch by Stitch Glanuloplasty Versus TIP","status":"COMPLETED","sponsor":"Sohag University","startDate":"2020-03-01","conditions":["Distal Penile Hypospadias"],"enrollment":40,"completionDate":"2022-03-01"},{"nctId":"NCT03139968","phase":"PHASE3","title":"Reduction of Catheterization Radiation Exposure Pad","status":"COMPLETED","sponsor":"J.P.S Henriques","startDate":"2017-01-16","conditions":["Radiation; Exposure Occupational","Coronary Interventions"],"enrollment":766,"completionDate":"2017-10-01"},{"nctId":"NCT05113082","phase":"","title":"Retrospective Study on Participants With Short Bowel Syndrome and Chronic Intestinal Failure That Underwent Transplantation in Brazil","status":"COMPLETED","sponsor":"Takeda","startDate":"2022-05-21","conditions":["Short Bowel Syndrome (SBS)"],"enrollment":7,"completionDate":"2022-10-15"},{"nctId":"NCT04788589","phase":"NA","title":"Sedation and Ventilator Weaning Protocol in PICU","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2020-09-01","conditions":["Mechanical Ventilation","Sedation"],"enrollment":50,"completionDate":"2022-07-01"},{"nctId":"NCT02980666","phase":"PHASE3","title":"Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support","status":"COMPLETED","sponsor":"Shire","startDate":"2017-01-13","conditions":["Short Bowel Syndrome"],"enrollment":10,"completionDate":"2020-01-21"},{"nctId":"NCT02865122","phase":"PHASE2,PHASE3","title":"Safety and Efficacy Study in Infant With SBS","status":"TERMINATED","sponsor":"Elgan Pharma Ltd.","startDate":"2017-03-20","conditions":["Short Bowel Syndrome"],"enrollment":2,"completionDate":"2018-03-22"},{"nctId":"NCT04394611","phase":"","title":"Metals and in Fetal Growth Restriction","status":"UNKNOWN","sponsor":"Cengiz Gokcek Women's and Children's Hospital","startDate":"2020-05-30","conditions":["Fetal Growth Restriction"],"enrollment":55,"completionDate":"2021-12-30"},{"nctId":"NCT00930644","phase":"PHASE3","title":"Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)","status":"COMPLETED","sponsor":"Shire","startDate":"2009-09-21","conditions":["Short Bowel Syndrome"],"enrollment":88,"completionDate":"2013-01-24"},{"nctId":"NCT01560403","phase":"PHASE3","title":"A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021","status":"COMPLETED","sponsor":"Shire","startDate":"2012-05-21","conditions":["Short Bowel Syndrome"],"enrollment":14,"completionDate":"2013-07-23"},{"nctId":"NCT04906031","phase":"PHASE2","title":"Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Jinan University","startDate":"2020-06-01","conditions":["Myelodysplastic Syndromes","Acute Myeloid Leukemia","Myeloid Malignancy","Temperature-Sensitive p53 Mutation","Sodium Stibogluconate","P53 Mutation"],"enrollment":5,"completionDate":"2024-02-01"},{"nctId":"NCT02682381","phase":"PHASE3","title":"Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition","status":"COMPLETED","sponsor":"Shire","startDate":"2016-06-23","conditions":["Short Bowel Syndrome"],"enrollment":59,"completionDate":"2017-08-18"},{"nctId":"NCT00081458","phase":"PHASE3","title":"Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome","status":"COMPLETED","sponsor":"Shire","startDate":"2004-05-25","conditions":["Short Bowel Syndrome"],"enrollment":84,"completionDate":"2007-07-06"},{"nctId":"NCT02340819","phase":"PHASE3","title":"Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)","status":"COMPLETED","sponsor":"Shire","startDate":"2014-12-18","conditions":["Short Bowel Syndrome"],"enrollment":11,"completionDate":"2018-11-05"},{"nctId":"NCT01952080","phase":"PHASE3","title":"A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome","status":"COMPLETED","sponsor":"Shire","startDate":"2013-11-14","conditions":["Short Bowel Syndrome"],"enrollment":42,"completionDate":"2015-01-09"},{"nctId":"NCT00798967","phase":"PHASE3","title":"Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects","status":"COMPLETED","sponsor":"Shire","startDate":"2008-11-25","conditions":["Short Bowel Syndrome"],"enrollment":86,"completionDate":"2011-01-25"},{"nctId":"NCT00172185","phase":"PHASE3","title":"Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)","status":"COMPLETED","sponsor":"Shire","startDate":"2005-01-10","conditions":["Short Bowel Syndrome"],"enrollment":65,"completionDate":"2008-01-24"},{"nctId":"NCT04884074","phase":"NA","title":"Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy","status":"UNKNOWN","sponsor":"Chinese University of Hong Kong","startDate":"2021-05-01","conditions":["Obesity","Gastro Esophageal Reflux Disease"],"enrollment":50,"completionDate":"2025-12-30"},{"nctId":"NCT00662012","phase":"PHASE2","title":"Sodium Stibogluconate Treatment of Leishmaniasis","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2002-06","conditions":["Leishmaniasis"],"enrollment":414,"completionDate":"2007-12"},{"nctId":"NCT01300975","phase":"PHASE2","title":"Intralesional Antimony for Bolivian Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Fundacion Nacional de Dermatologia","startDate":"2011-01","conditions":["Leishmaniasis","Cutaneous Leishmaniasis"],"enrollment":90,"completionDate":"2012-07"},{"nctId":"NCT04733066","phase":"","title":"Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2020-09-01","conditions":["Short Bowel Syndrome","Intestinal Failure"],"enrollment":40,"completionDate":"2022-09"},{"nctId":"NCT02987569","phase":"NA","title":"Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2016-07","conditions":["Short Bowel Syndrome","Malabsorption","Malnutrition"],"enrollment":83,"completionDate":"2020-06"},{"nctId":"NCT04379856","phase":"PHASE1,PHASE2","title":"Proof of Concept Study in Patients With Short Bowel Syndrome","status":"UNKNOWN","sponsor":"9 Meters Biopharma, Inc.","startDate":"2020-06-23","conditions":["Short Bowel Syndrome"],"enrollment":12,"completionDate":"2020-12-31"},{"nctId":"NCT00498979","phase":"PHASE1","title":"Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2007-05","conditions":["Stage IV Melanoma"],"enrollment":22,"completionDate":"2012-01"},{"nctId":"NCT04450472","phase":"","title":"Nonthyroidal Illness Syndrome in SBS","status":"COMPLETED","sponsor":"Jinling Hospital, China","startDate":"2016-12-31","conditions":["Nonthyroidal Illness Syndrome","Short Bowel Syndrome"],"enrollment":51,"completionDate":"2018-12-31"},{"nctId":"NCT00884377","phase":"PHASE2","title":"Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2004-02","conditions":["Cutaneous Leishmaniasis"],"enrollment":56,"completionDate":"2009-03"},{"nctId":"NCT00657618","phase":"PHASE1,PHASE2","title":"Use of Sodium Stibogluconate as a Treatment for Leishmaniasis","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2004-10","conditions":["Leishmaniasis"],"enrollment":77,"completionDate":"2015-04"},{"nctId":"NCT04150302","phase":"","title":"Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2020-01","conditions":["SBS - Short Bowel Syndrome"],"enrollment":250,"completionDate":"2021-06"},{"nctId":"NCT02907775","phase":"NA","title":"Multi-channel Stimulation for Post Stroke Spasticity (MUSTS)","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2016-09-30","conditions":["Muscle Spasticity","Stroke"],"enrollment":16,"completionDate":"2018-09-30"},{"nctId":"NCT00657917","phase":"PHASE2","title":"Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396","status":"TERMINATED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2006-12-20","conditions":["Cutaneous Leishmaniasis"],"enrollment":1,"completionDate":"2010-06-24"},{"nctId":"NCT01674478","phase":"PHASE2","title":"Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2012-10","conditions":["Prematurity","Intestine Perforation","Necrotizing Enterocolitis (NEC)","Short Bowel Syndrome (SBS)"],"enrollment":18,"completionDate":"2015-03-17"},{"nctId":"NCT00629200","phase":"PHASE1","title":"Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-09-13","conditions":["Advanced Cancer","Solid Tumors"],"enrollment":33,"completionDate":"2010-02-10"},{"nctId":"NCT03242369","phase":"NA","title":"Comparison of the Effectiveness of Bowel Preparations Before Colonoscopy","status":"UNKNOWN","sponsor":"Military University Hospital, Prague","startDate":"2017-09-01","conditions":["Colorectal Neoplasms"],"enrollment":400,"completionDate":"2019-03-31"},{"nctId":"NCT00311558","phase":"PHASE1","title":"Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2005-10","conditions":["Cancer"],"enrollment":18,"completionDate":"2012-01"},{"nctId":"NCT03271853","phase":"","title":"Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.","status":"SUSPENDED","sponsor":"First Sense Medical, LLC","startDate":"2017-11-03","conditions":["Breast Neoplasm Female","Cancer, Breast","Thermography"],"enrollment":2000,"completionDate":"2026-09-01"},{"nctId":"NCT01141088","phase":"NA","title":"Two Bilateral Metal Stenting in Hilar Malignancy","status":"UNKNOWN","sponsor":"Soon Chun Hyang University","startDate":"2016-04-01","conditions":["Malignant Hilar Stricture","Bilateral Stent Insertion"],"enrollment":80,"completionDate":"2018-09-30"},{"nctId":"NCT02690025","phase":"PHASE2","title":"A Phase 2 Trial Testing ZP1848 in Patients With SBS","status":"COMPLETED","sponsor":"Zealand Pharma","startDate":"2016-02","conditions":["Short Bowel Syndrome"],"enrollment":18,"completionDate":"2017-05"},{"nctId":"NCT01067443","phase":"PHASE2","title":"Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2010-03","conditions":["Primary Visceral Leishmaniasis"],"enrollment":151,"completionDate":"2011-06"},{"nctId":"NCT02819531","phase":"NA","title":"Efficacy CompariSon of Pre-stenting Atherectomy Versus Scoring ballooN for calcifieD Coronary Lesions Coronary Lesions","status":"UNKNOWN","sponsor":"North Texas Veterans Healthcare System","startDate":"2016-06","conditions":["Atherosclerosis","Coronary Artery Disease"],"enrollment":30,"completionDate":""},{"nctId":"NCT01381055","phase":"PHASE2,PHASE3","title":"Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Paulo Roberto Lima Machado","startDate":"2012-03","conditions":["Cutaneous Leishmaniasis"],"enrollment":164,"completionDate":"2015-10"},{"nctId":"NCT01441310","phase":"PHASE2","title":"Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2010-07","conditions":["Gastric Cancer"],"enrollment":101,"completionDate":"2016-08"},{"nctId":"NCT02142582","phase":"NA","title":"Comparison of Different Oral Rehydration Solutions","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-05","conditions":["Short Bowel Syndrome"],"enrollment":28,"completionDate":"2016-04"},{"nctId":"NCT00255567","phase":"PHASE3","title":"Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2004-11","conditions":["Visceral Leishmaniasis"],"enrollment":1142,"completionDate":"2010-01"},{"nctId":"NCT02699320","phase":"","title":"Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications","status":"COMPLETED","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2015-06","conditions":["Short Bowel Syndrome","Complications"],"enrollment":33,"completionDate":"2016-01"},{"nctId":"NCT02063841","phase":"EARLY_PHASE1","title":"Digestive Endoscopy Suite Radiation Controlling Protective Strategies","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-08","conditions":["Radiation Exposure"],"enrollment":2,"completionDate":"2013-11"},{"nctId":"NCT02246816","phase":"PHASE3","title":"A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001","status":"WITHDRAWN","sponsor":"Marathon Pharmaceuticals, LLC","startDate":"2015-02","conditions":["Short Bowel Syndrome","Short Gut Syndrome","SBS","Short Gut"],"enrollment":0,"completionDate":"2018-02"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"F79059A38U","SPL_ID":"2cc87194-4ca1-f4af-e063-6294a90a596b","chemblId":"CHEMBL4297652"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Washington Homeopathic Products","relationship":"Original Developer"}],"publicationCount":8311,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"originalDeveloper":"Washington Homeopathic Products","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Washington Homeopathic Products","companyId":"washington-homeopathic-products","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:23.759758+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}